Περίληψη:
The serine/threonine kinase mechanistic target of rapamycin (mTOR) plays a pivotal role in the regulation of cell proliferation, survival, and motility in response to availability of energy and nutrients as well as mitogens. The mTOR signaling axis regulates important biological processes, including cellular growth, metabolism, and survival in many tissues. In the skin, dysregulation of PI3K/AKT/mTOR pathway may lead to severe pathological conditions characterized by uncon-trolled proliferation and inflammation, including skin hyperproliferative as well as malignant dis-eases. Herein, we provide an update on the current knowledge regarding the pathogenic implica-tion of the mTOR pathway in skin diseases with inflammatory features (such as psoriasis, atopic dermatitis, pemphigus, and acne) and malignant characteristics (such as cutaneous T cell lymphoma and melanoma) while we critically discuss current and future perspectives for therapeutic targeting of mTOR axis in clinical practice. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Συγγραφείς:
Karagianni, F.
Pavlidis, A.
Malakou, L.S.
Piperi, C.
Papadavid, E.
